Native hypovitaminosis d in ckd patients: From experimental evidence to clinical practice

Carlo Alfieri; Oksana Ruzhytska; Simone Vettoretti; Lara Caldiroli; Mario Cozzolino; Piergiorgio Messa

doi:10.3390/nu11081918

Native hypovitaminosis d in ckd patients: From experimental evidence to clinical practice

Carlo Alfieri, Oksana Ruzhytska, Simone Vettoretti, Lara Caldiroli, Mario Cozzolino, Piergiorgio Messa

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Review article › peer-review

Abstract

Native hypovitaminosis D (n-hVITD) is frequently found from the early stages of chronic kidney disease (CKD) and its prevalence increases with CKD progression. Even if the implications of n-hVITD in chronic kidney disease-mineral bone disorder (CKD-MBD) have been extensively characterized in the literature, there is a lot of debate nowadays about the so called “unconventional effects” of native vitamin D (25(OH)VitD) supplementation in CKD patients. In this review, highlights of the dimension of the problem of n-hVITD in CKD stages 2–5 ND patients will be presented. In addition, it will focus on the “unconventional effects” of 25(OH)VitD supplementation, the clinical impact of n-hVITD and the most significant interventional studies regarding 25(OH)VitD supplementation in CKD stages 2–5 ND.

Original language	English
Article number	1918
Journal	Nutrients
Volume	11
Issue number	8
DOIs	https://doi.org/10.3390/nu11081918
Publication status	Published - Aug 1 2019

Keywords

Cardiovascular risk
CKD
Mineral metabolism
Vitamin D
Vitamin D supplementation

ASJC Scopus subject areas

Food Science
Nutrition and Dietetics

Access to Document

10.3390/nu11081918

Cite this

@article{0f21a66d787648baad20b24c6de3e6e4,

title = "Native hypovitaminosis d in ckd patients: From experimental evidence to clinical practice",

abstract = "Native hypovitaminosis D (n-hVITD) is frequently found from the early stages of chronic kidney disease (CKD) and its prevalence increases with CKD progression. Even if the implications of n-hVITD in chronic kidney disease-mineral bone disorder (CKD-MBD) have been extensively characterized in the literature, there is a lot of debate nowadays about the so called “unconventional effects” of native vitamin D (25(OH)VitD) supplementation in CKD patients. In this review, highlights of the dimension of the problem of n-hVITD in CKD stages 2–5 ND patients will be presented. In addition, it will focus on the “unconventional effects” of 25(OH)VitD supplementation, the clinical impact of n-hVITD and the most significant interventional studies regarding 25(OH)VitD supplementation in CKD stages 2–5 ND.",

keywords = "Cardiovascular risk, CKD, Mineral metabolism, Vitamin D, Vitamin D supplementation",

author = "Carlo Alfieri and Oksana Ruzhytska and Simone Vettoretti and Lara Caldiroli and Mario Cozzolino and Piergiorgio Messa",

year = "2019",

month = aug,

day = "1",

doi = "10.3390/nu11081918",

language = "English",

volume = "11",

journal = "Nutrients",

issn = "2072-6643",

publisher = "NLM (Medline)",

number = "8",

}

TY - JOUR

T1 - Native hypovitaminosis d in ckd patients

T2 - From experimental evidence to clinical practice

AU - Alfieri, Carlo

AU - Ruzhytska, Oksana

AU - Vettoretti, Simone

AU - Caldiroli, Lara

AU - Cozzolino, Mario

AU - Messa, Piergiorgio

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Native hypovitaminosis D (n-hVITD) is frequently found from the early stages of chronic kidney disease (CKD) and its prevalence increases with CKD progression. Even if the implications of n-hVITD in chronic kidney disease-mineral bone disorder (CKD-MBD) have been extensively characterized in the literature, there is a lot of debate nowadays about the so called “unconventional effects” of native vitamin D (25(OH)VitD) supplementation in CKD patients. In this review, highlights of the dimension of the problem of n-hVITD in CKD stages 2–5 ND patients will be presented. In addition, it will focus on the “unconventional effects” of 25(OH)VitD supplementation, the clinical impact of n-hVITD and the most significant interventional studies regarding 25(OH)VitD supplementation in CKD stages 2–5 ND.

AB - Native hypovitaminosis D (n-hVITD) is frequently found from the early stages of chronic kidney disease (CKD) and its prevalence increases with CKD progression. Even if the implications of n-hVITD in chronic kidney disease-mineral bone disorder (CKD-MBD) have been extensively characterized in the literature, there is a lot of debate nowadays about the so called “unconventional effects” of native vitamin D (25(OH)VitD) supplementation in CKD patients. In this review, highlights of the dimension of the problem of n-hVITD in CKD stages 2–5 ND patients will be presented. In addition, it will focus on the “unconventional effects” of 25(OH)VitD supplementation, the clinical impact of n-hVITD and the most significant interventional studies regarding 25(OH)VitD supplementation in CKD stages 2–5 ND.

KW - Cardiovascular risk

KW - CKD

KW - Mineral metabolism

KW - Vitamin D

KW - Vitamin D supplementation

UR - http://www.scopus.com/inward/record.url?scp=85071502074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071502074&partnerID=8YFLogxK

U2 - 10.3390/nu11081918

DO - 10.3390/nu11081918

M3 - Review article

C2 - 31443249

AN - SCOPUS:85071502074

VL - 11

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 8

M1 - 1918

ER -

Native hypovitaminosis d in ckd patients: From experimental evidence to clinical practice

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this